* Ovid Therapeutics press release [https://seekingalpha.com/pr/20199310-ovid-therapeutics-reports-business-updates-and-second-quarter-2025-financial-results] (NASDAQ:OVID [https://seekingalpha.com/symbol/OVID]): Q2 GAAP EPS of -$0.06.
* Revenue of $6.3M.
*
MORE ON OVID THERAPEUTICS
* Seeking Alpha’s Quant Rating on Ovid Therapeutics [https://seekingalpha.com/symbol/OVID/ratings/quant-ratings]
* Historical earnings data for Ovid Therapeutics [https://seekingalpha.com/symbol/OVID/earnings]
* Financial information for Ovid Therapeutics [https://seekingalpha.com/symbol/OVID/income-statement]
Ovid Therapeutics GAAP EPS of -$0.06, revenue of $6.3M
Published 2 months ago
Aug 13, 2025 at 2:04 PM
Positive
Auto